Evidence map›Paper›PMID 27327144›Full record

ArticleMethods (San Diego, Calif.)2017

Quantifying MHC dextramer-induced NFAT activation in antigen-specific T cells as a functional response parameter.

Orla Maguire, George L Chen, Theresa E Hahn, Liselotte Brix, Philip L McCarthy, Paul K Wallace, Hans Minderman

Open access · greenAbstract read
In one paragraph

Article in Methods (San Diego, Calif.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Orla MaguireDepartment of Flow and Image Cytometry, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Electronic address: orla.maguire@roswellpark.org.
George L ChenDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Theresa E HahnDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Liselotte BrixImmudex, DK-2100, Copenhagen, Denmark.
Philip L McCarthyDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Paul K WallaceDepartment of Flow and Image Cytometry, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Hans MindermanDepartment of Flow and Image Cytometry, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Associate-Director Flow and Image Cytometry Roswell Park ComprehensiveCancer CenterR50CA211108 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI HANS MINDERMAN · 2016 to 2026
$3.0M
Imaging Flow CytometerS10OD018048 · OD · ROSWELL PARK CANCER INSTITUTE CORP · PI MINDERMAN, HANS · 2014 to 2014
$400k
NCI NIH HHS P30 CA016056NCI NIH HHS R50 CA211108NIH HHS S10 OD018048
6 · The paper itself

Abstract

MHC-multimers are reagents used for the detection and enumeration of antigen-specific T cells (ASTs). These reagents exploit the mechanism by which T cell receptors (TCR) on cytotoxic CD8 T cells recognize specific antigens in the context of a major histocompatibility complex (MHC) molecule during antigen presentation. MHC-multimers are fluorescently-labeled dextran polymers that carry MHC Class I molecules and peptide sequences that can be modified to represent specific cognate sequences of the antigen of interest with dextramers having a 10-fold multiplicity of the MHC/peptide combination within a single multimer. Since the binding of antigen-specific dextramers mimics antigen presentation to the TCR, the present study sought to determine whether this TCR engagement on the AST was sufficient to elicit a functional T cell response. The effect of binding of CMV specific dextramers on the activation of the NFAT signal transduction cascade was assessed in peripheral blood from bone marrow transplant recipients previously determined to be positive for CMV-ASTs (CASTs). NFAT activation was quantified by measuring nuclear translocation of NFAT1 in CD8+ CASTs and CD8+ non-CASTs by imaging flow cytometry. Our results demonstrate that an increase in the nuclear localization of NFAT1 was detectable in the CASTs following the CMV-dextramer binding and could be observed as early as 10min post-exposure. The NFAT1 activation correlated with a downstream functional response in the form of interferon gamma production. Sample preparation, temperature, and duration of dextramer exposure were important parameters affecting the dextramer-induced NFAT activation with 2h exposure in whole blood at room temperature being the optimal of the conditions tested. Intra- and inter-individual heterogeneity was observed with regards to the NFAT activation in the CASTs. Importantly, no effect of the dextramers was observed in the CD8+ non-CASTs, and therefore dextramer negative cell populations. Exposure to PMA/ionomycin following dextramer exposure resulted in a homogeneous NFAT activation in both the dextramer-positive but NFAT1 nonresponsive CAST and non-CAST cells. Thus, the data demonstrate that binding of antigen-specific dextramers to ASTs specifically results in activation of NFAT, that the NFAT activation correlates with a downstream functional response and that the response can be heterogeneous. This functional parameter may provide insight to the issue whether enumeration alone of ASTs is a sufficient parameter to assess an individual's immune status against a specific antigen.

Indexed as

Major Histocompatibility ComplexAntigen PresentationCytomegalovirusFlow CytometryFluorescent DyesGene Expression RegulationHematopoietic Stem Cell TransplantationHumansImage CytometryInterferon-gammaIonomycinLeukemiaLymphocyte ActivationNFATC Transcription FactorsPhycoerythrinPrimary Cell CultureFluorescent DyesInterferon-gammaIonomycinNFATC2 protein, humanNFATC Transcription FactorsPhycoerythrinReceptors, Antigen, T-CellTetradecanoylphorbol AcetateAntigen specificityDextramersImaging flow cytometryNFAT

Identifiers

PMID27327144
PMCPMC5821144
OpenAlexW2443003462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.